Indian Immunologicals receives regulatory approval for Measles-Rubella vaccine
This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years
This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years